Log in

Orthocell Stock Price, Forecast & Analysis (ASX:OCC)

A$0.53
-0.02 (-3.64 %)
(As of 11/14/2019 07:51 AM ET)
Today's Range
A$0.53
Now: A$0.53
A$0.55
50-Day Range
A$0.38
MA: A$0.48
A$0.64
52-Week Range
A$0.11
Now: A$0.53
A$0.78
Volume803,266 shs
Average VolumeN/A
Market Capitalization$81.80 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and related technologies for the repair and regeneration of human tendon, bone, nerve, and cartilage defects in Australia and Poland. The company's principal products include CelGro, a naturally derived collagen medical device for soft tissue repair that is under clinical trials for use as an augment to the surgical repair of tendons, peripheral nerves, bones, and articular cartilage; and Ortho-ATI, an autologous tenocyte implantation for chronic treatment resistant tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation for the treatment of symptomatic defects of the articulating cartilage of the joints, primarily in the knee and ankle. Orthocell Limited was founded in 2006 and is based in Murdoch, Australia.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 8 9360 2888

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$945,657.00
Cash FlowA$0.07 per share
Book ValueA$0.07 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$81.80 million
Next Earnings DateN/A
OptionableNot Optionable

Receive OCC News and Ratings via Email

Sign-up to receive the latest news and ratings for OCC and its competitors with MarketBeat's FREE daily newsletter.


Orthocell (ASX:OCC) Frequently Asked Questions

What is Orthocell's stock symbol?

Orthocell trades on the ASX under the ticker symbol "OCC."

Has Orthocell been receiving favorable news coverage?

Media headlines about OCC stock have trended somewhat negative recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Orthocell earned a daily sentiment score of -1.4 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Orthocell.

Who are some of Orthocell's key competitors?

What other stocks do shareholders of Orthocell own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthocell investors own include Plug Power (PLUG) and GP Strategies (GPX).

Who are Orthocell's key executives?

Orthocell's management team includes the folowing people:
  • Dr. Stewart James Washer B.Sc., BSc (Hons), Ph.D., Exec. Chairman (Age 49)
  • Mr. Paul Anderson, CEO, MD & Exec. Director (Age 53)
  • Ms. Nicole Telford, Chief Financial Officer
  • Prof. Ming Hao Zheng, Chief Scientific Officer and Member of Medical & Scientific Advisory Board
  • Monique Cannon, Regulatory Affairs & Compliance Mang.

What is Orthocell's stock price today?

One share of OCC stock can currently be purchased for approximately A$0.53.

How big of a company is Orthocell?

Orthocell has a market capitalization of $81.80 million and generates $945,657.00 in revenue each year. View Additional Information About Orthocell.

What is Orthocell's official website?

The official website for Orthocell is http://www.orthocell.com.au/.

How can I contact Orthocell?

The company can be reached via phone at 61 8 9360 2888.


MarketBeat Community Rating for Orthocell (ASX OCC)

Community Ranking:  1.5 out of 5 (star half star)
Outperform Votes:  3 (Vote Outperform)
Underperform Votes:  7 (Vote Underperform)
Total Votes:  10
MarketBeat's community ratings are surveys of what our community members think about Orthocell and other stocks. Vote "Outperform" if you believe OCC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OCC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/14/2019 by MarketBeat.com Staff

Featured Article: What is a price target?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel